Bienvenu, Thierry https://orcid.org/0000-0002-5953-2728
Lebrun, Nicolas
Clarke, Julia
Duriez, Philibert
Gorwood, Philip
Ramoz, Nicolas
Funding for this research was provided by:
Fondation Maladies Rares (#11632)
Article History
Received: 14 March 2019
Accepted: 31 July 2019
First Online: 6 August 2019
Compliance with ethical standards
:
: Philip Gorwood received during the last 5 years fees for presentations at congresses or participation in scientific boards from Alcediag-Alcen, AstraZeneca, Bristol-Myers-Squibb, GSK, Janssen, Lilly, Lundbeck, Otsuka and Servier, none of them being related to the present study. All other authors declare no competing interests. GP is not employed by a commercial company. Other authors report no conflict of interest.